Pharmaceutical Promotion to Physicians and First Amendment Rights  

Oleh:

Kesselheim, Aaron S. ; Avorn, Jerry

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 358 no. 16 (Apr. 2008), page 1727.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In mid-February, the Food and Drug Administration (FDA) proposed a change in its rules governing pharmaceutical promotion that would widen the ability of drug manufacturers to distribute information on unapproved uses of their products.1 This proposal has rekindled the debate over the rights of drug makers to promote their medications to physicians. Studies have highlighted the substantial effect of promotional statements on the prescribing behavior of physicians, and litigation has revealed that some manufacturers have depicted the risks and benefits of their products inaccurately.2 A growing number of states are working to curb inappropriate pharmaceutical promotion by restricting electronic marketing . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali